117 related articles for article (PubMed ID: 37783483)
1. Correction: Outcomes associated with treatment to all sites of disease in patients with stage IVB cancer of the cervix.
Int J Gynecol Cancer; 2023 Oct; 33(10):1673. PubMed ID: 37783483
[No Abstract] [Full Text] [Related]
2. Outcomes associated with treatment to all sites of disease in patients with stage IVB cancer of the cervix.
Peleg Hasson S; Felder S; Helpman L; Taylor A; Shalamov M; Abuakar S; Bauer S; Shapira-Frommer R; Greenhouse I; Korach J; Rabin T; Goldstein J; Saad A
Int J Gynecol Cancer; 2023 May; 33(5):683-691. PubMed ID: 36963801
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel and carboplatin chemotherapy for treating patients with stage IVB or recurrent non-squamous cell carcinoma of the uterine cervix: a phase II study.
Shimada M; Sato S; Shoji T; Nagao S; Tokunaga H; Sueoka K; Takehara K; Nakamura K; Yamaguchi S; Kigawa J
Int J Clin Oncol; 2021 Jul; 26(7):1314-1321. PubMed ID: 33826028
[TBL] [Abstract][Full Text] [Related]
4. Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix.
Paton F; Paulden M; Saramago P; Manca A; Misso K; Palmer S; Eastwood A
Health Technol Assess; 2010 May; 14 Suppl 1():55-62. PubMed ID: 20507804
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy.
Ittiamornlert P; Ruengkhachorn I
BMC Cancer; 2019 Jan; 19(1):51. PubMed ID: 30630439
[TBL] [Abstract][Full Text] [Related]
6. Association of pretreatment SUV
Shou H; Yasuo Y; Yuan S; Lou H; Ni J
Int J Gynaecol Obstet; 2021 Jan; 152(1):112-117. PubMed ID: 33141954
[TBL] [Abstract][Full Text] [Related]
7. Survival benefit of surgical treatment for patients with stage IVB endometrial cancer: a propensity score-matched SEER database analysis.
Zhang Y; Hao Z; Yang S
J Obstet Gynaecol; 2023 Dec; 43(1):2204937. PubMed ID: 37170930
[TBL] [Abstract][Full Text] [Related]
8. Surgery of primary sites for stage IVB cervical cancer patients receiving chemoradiotherapy: a population-based study.
Li H; Pang Y; Cheng X
J Gynecol Oncol; 2020 Jan; 31(1):e8. PubMed ID: 31788998
[TBL] [Abstract][Full Text] [Related]
9. Definitive radiation therapy in the treatment of carcinoma of the uterine cervix. Treatment results and prognostic factors.
Busch M; Dühmke E; Kuhn W; Teichmann A
Strahlenther Onkol; 1991 Nov; 167(11):628-37. PubMed ID: 1962276
[TBL] [Abstract][Full Text] [Related]
10. Outcomes and toxicities for the treatment of stage IVB cervical cancer.
Hwang JH; Lim MC; Seo SS; Kang S; Park SY; Kim JY
Arch Gynecol Obstet; 2012 Jun; 285(6):1685-93. PubMed ID: 22173823
[TBL] [Abstract][Full Text] [Related]
11. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
12. Should isolated peritoneal carcinomatosis from colorectal cancer be sub-classified into stage IVB in era of modern chemotherapy?
Ishida H; Kumamoto K; Ishibashi K; Hatano S; Matsuzawa T; Okada N; Kumagai Y; Baba H; Haga N
Tech Coloproctol; 2013 Dec; 17(6):647-52. PubMed ID: 23389285
[TBL] [Abstract][Full Text] [Related]
13. The FIGO Stage IVA Versus IVB of Ovarian Cancer: Prognostic Value and Predictive Value for Neoadjuvant Chemotherapy.
Tajik P; van de Vrie R; Zafarmand MH; Coens C; Buist MR; Vergote I; Bossuyt PMM; Kenter GG
Int J Gynecol Cancer; 2018 Mar; 28(3):453-458. PubMed ID: 29324537
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of different metastatic sites for patients with FIGO stage IVB endometrial cancer after surgery: A SEER database analysis.
Li H; Zhang R; Chen C; Wu C; Lin H; Li J; Lin Z
J Surg Oncol; 2020 Oct; 122(5):941-948. PubMed ID: 32682330
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes and complications in FIGO stage IIIC and IVB endometrioid endometrial cancer patients presenting as nodal spreads following systematic lymphadenectomy and adjuvant therapy.
Kong TW; Jo E; Son JH; Paek J; Chang SJ; Ryu HS
J Obstet Gynaecol Res; 2021 Sep; 47(9):3322-3330. PubMed ID: 34196087
[TBL] [Abstract][Full Text] [Related]
16. Status of treatment for the overall population of patients with stage IVb endometrial cancer, and evaluation of the role of preoperative chemotherapy: a retrospective multi-institutional study of 426 patients in Japan.
Eto T; Saito T; Shimokawa M; Hatae M; Takeshima N; Kobayashi H; Kasamatsu T; Yoshikawa H; Kamura T; Konishi I
Gynecol Oncol; 2013 Dec; 131(3):574-80. PubMed ID: 24016406
[TBL] [Abstract][Full Text] [Related]
17. Review of Treatment and Prognosis of Stage IVB Cervical Carcinoma.
Usami T; Takahashi A; Matoda M; Okamoto S; Kondo E; Kanao H; Umayahara K; Takeshima N
Int J Gynecol Cancer; 2016 Sep; 26(7):1239-45. PubMed ID: 27643648
[TBL] [Abstract][Full Text] [Related]
18. Stage IVb thymic carcinoma: patients with lymph node metastases have better prognoses than those with hematogenous metastases.
Yang Y; Fan XW; Wang HB; Xu Y; Li DD; Wu KL
BMC Cancer; 2017 Mar; 17(1):217. PubMed ID: 28347273
[TBL] [Abstract][Full Text] [Related]
19. Race and nodal disease status are prognostic factors in patients with stage IVB cervical cancer.
Nishio S; Matsuo K; Yonemoto K; Shimokawa M; Hosaka M; Kodama M; Miyake TM; Ushijima K; Kamura T; Westin SN; Soliman PT; Coleman RL
Oncotarget; 2018 Aug; 9(64):32321-32330. PubMed ID: 30190789
[TBL] [Abstract][Full Text] [Related]
20. Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapy.
Zighelboim I; Taylor NP; Powell MA; Gibb RK; Rader JS; Mutch DG; Grigsby PW
Radiat Med; 2006 Nov; 24(9):625-30. PubMed ID: 17111271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
